Interventional radiology procedures: Addressing the needs of the cardiovascular patient

Reviews in Cardiovascular Medicine

Volumn 9, Issue SUPPL. 1, 2008, Pages

  Ferrara, Stephen ^a  

^a California Radiology Medical Associates Inc   (United States)

Author keywords

Cardiovascular disease; Hypertension; Interventional radiology; Sedation

Indexed keywords

ANALGESIC AGENT; HYPNOTIC AGENT; SEDATIVE AGENT;

ANALGESIA; ANESTHESIA; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; HUMAN; HYPERTENSION; INTERVENTIONAL RADIOLOGY; KIDNEY DISEASE; PATIENT CARE; REVIEW; RISK FACTOR; SEDATION;

CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; RADIOLOGY, INTERVENTIONAL; RISK ASSESSMENT; RISK FACTORS; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 42249102938     PISSN: 15306550     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. American Heart Association. Heart attack, stroke and cardiac arrest warning signs. http://www.americanheart.org/presenter.jhtml?identifier=3053. Accessed January 20, 2008.
2. US Center for Disease Control. National diabetes fact sheet. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2005.pdf. Accessed January 20, 2008.
3. American Heart Association. Risk factors and coronary heart disease. http://www.americanheart.org/presenter.jhtml;jsessionid=V3V03A3IXR2VACQFCXPSDSQ? identifier=4726. Accessed January 20, 2008.
4. National Heart Lung and Blood Institute. What is peripheral arterial disease? http://www.nhlbi.nih.gov/health/dci/Diseases/pad/pad_what.html. Accessed January 24, 2008.
5. American Heart Association. Heart attack and angina statistics. http://www.americanheart.org/presenter.jhtml?identifier=4591. Accessed February 1, 2008.
6. Kennedy PT, Kelly IM, Loan WC, et al. Conscious sedation and analgesia for routine aortofemoral arteriography: A prospective evaluation. Radiology. 2000;216:660-664.
7. Practice guidelines for sedation and analgesia by non-anesthesiologists. An updated report by the American Society of Anesthesiologists Task Force on Sedation and Analgesia by Non-Anesthesiologists. Anesthesiology. 2002;96:1004-1017.
8. Martin ML, Lennox PH. Sedation and analgesia in the interventional radiology department. J Vasc Interv Radiol. 2003;14:1119-1128.
9. Chou J, Stritchartz GR, Lo EH. Pharmacology of excitatory and inhibitory neurotransmission. In: Golan DE, Tahjlan, AH Jr, eds. Principles of Pharmacology: The Pathophysiologic Basis of Drug Therapy. Philadelphia, PA: Lippincott Williams & Wilkins; 2005:153-155.
10. Greenblatt DJ, Abernethy DR, Locniskar A, et al. Effect of age, gender, and obesity on midazolam kinetics. Anesthesiology.1984;61:27-35.
11. Cragg AH, Smith TP, Berbaum KS, et al. Randomized double blind trial of midazolam/placebo and midazolam/fentanyl for sedation and analgesia in lower extremity angiography. Am J Roentgenol. 1991;157:173-176.
12. American Society of Nephrology. The kidney and heart disease connection. http://www.asn-online.org/facts_and_statistics/pdf/ASN%20Kidney%20Heart.pdf. Accessed February 4, 2008.
13. McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention incidence, risk factors, and relationship to mortality. Am J Med. 1997;103:368-375.
14. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast media-associated nephropathy: Randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med. 2002;162:329-336.
15. Tepel M, Van Der Giet M, Schwarzfeld C, et al. Prevention of radiographic-contrast-agent-induced reduction in renal function by acetylcysteine. N Engl J Med. 2000;343:180-184.
16. Merten GJ, Burgess,WP Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial. JAMA. 2004;291:2328-2324.
17. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial. Kidney Int. 1995;47:254-261.
18. Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med. 2003;348:491-499.
19. Manske CL, Sprafica JM, Strony JT, Wang Y. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med. 1990;89:615-620.
20. Spargias K, Alexopoulos E, Kyrzopoulos S, et al. Ascorbic acid prevents contrast-mediated nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. Circulation. 2004;110:2837-2842.
21. Huber W, Ilgmann K, Page M, et al. Effect of theophylline on contrast material-induced nephropathy in patients with chronic renal insufficiency: Controlled, randomized, double-blinded study. Radiology. 2002;223:772-779.
22. McCullough PA, Stacul F, Davidson C, et al. Strategies to reduce the risk of contrast-induced nephropathy. Am J Cardiol. 2006;98(suppl 6A):59K-77K.
23. Nash K, Hafees A, Hou S. Hospital-acquired renal insufficiency. Am J Kidney Dis. 2002;39:930-936.
24. Trivedi HS, Moore H, Nasr S, Aggarwal K. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract. 2003;93:C29-C34.
25. Hyman DJ, Pavlik VN. Characteristics of patients with uncontrolled hypertension in the United States. N Engl J Med. 2001;345:479-486.
26. US Preventive Services Task Force. Guide to Clinical Preventive Services. 2nd ed. Baltimore, MD: Williams & Wilkins; 1996.
27. Waybill MM, Waybill PN. A practical approach to hypertension in the 21st century. J Vasc Interv Radiol. 2003;14:961-975.
28. The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1997;157:2413-2446.
29. Levy D, Larson MG, Vasan RS, et al. The progression from hypertension to congestive heart failure. JAMA. 1996;275:1557-1562.
30. Vakili BA, Okin PM, Devereux RB. Prognostic implications of left ventricular hypertrophy. Am Heart J. 2001;141:334-341.
31. Nano G, Dalainas I, Bianchi P, et al. Ballooning-induced bradycardia during carotid stenting in primary stenosis and restenosis. Neuroradiology. 2006;48:533-536.
32. Faries PL, Trocciola SM, DeRubertis B, et al. Hemodynamic instability after carotid artery angioplasty and stenting is associated with increased age and female gender. Vasc Dis Manag. 2006;3:200-205.
33. Qureshi AI, Luft AR, Sharma M, et al. Frequency and determinants of postprocedural hemodynamic instability after carotid angioplasty and stenting. Stroke. 1999;30:2096-2093.
34. American Society of Anesthesiologists. http://www.asahq.org/clinical/ physicalstatus.htm. Accessed March 11, 2008.